IQV IQVIA Holdings Inc. logo

IQV IQVIA Holdings Inc.

Healthcare
$167.90-0.07%ClosedMarket Cap: $28.02B

As of 2026-05-25

Valuation

View Details

P/E (TTM)

20.88

PEG

P/B

4.54

P/S

1.68

EV/EBITDA

8.01

DCF Value

$288.20

FCF Yield

9.5%

Div Yield

0.0%

Margins & Returns

Gross Margin

26.1%

Operating Margin

13.9%

Net Margin

8.3%

ROE

22.5%

ROA

4.7%

ROIC

8.4%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$4.15B$274.0M$
Q4 null$4.36B$514.0M$
FY null$16.31B$1.36B$
Q3 null$4.10B$331.0M$

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$223.75

Target (Median)

$222.50

Target Range

$185.00 - $250.00

4 Strong Buy17 Buy2 Hold0 Sell0 Strong Sell
Evercore ISI GroupOutperform
2026-04-08
TD CowenBuy
2026-03-09
BarclaysOverweight
2026-03-06
Truist SecuritiesBuy
2026-02-19
JefferiesBuy
2026-02-06

Trading Activity

Insider Trades

View All
Wims Morris Lesliedirector
SellMon May 11
GOGGINS COLLEEN Adirector
SellMon May 11
Fasano Jimdirector
SellMon May 11
DANHAKL JOHN Gdirector
SellMon May 11
Wims Morris Lesliedirector
SellMon Apr 27

Congress Trades

View All
Kevin HernSell
Mon Apr 06

Company Info

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Country

US

Exchange

Beta

1.18

IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with HealthCore, Inc. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.

Peers